Biocon Ltd reported a 49 percent slump in consolidated net profit at INR 82 crore for the quarter ended September 30, 2022.
Biocon Q2FY23 results out: Revenue up by 26%
Categories
biosimilars
Decoding India’s leading API development company – Dr Reddy’s Laboratories
About Company: Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company by global
Panacea Biotech Q1FY23 Net profit soars by 2%
Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores
Decoding Panacea Biotec Limited: India’s leading Vaccine Developer
Summary: Universal Immunization Program (UIP) in India is one of the largest public health programs in the world. It targets vaccinating ~30.4
Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits
Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales of biosimilar